title: Osteopenia in children and adolescents with hyperprolactinemia.
abstract: Three patients with hyperprolactinemia due to pituitary adenomas (two patients) or empty sella (one patient) and osteopenia are described. Their ages at presentation ranged from 8 to 17 years. Each patient was treated with cabergoline. Serum prolactin levels became normal in all patients within one month. Bone density and pubertal stage improved after 12 months of treatment.
authors.affiliation: 4th Pediatric Department, Aristotle University of Thessaloniki, Greece.
authors.forename: A
authors.initials: A
authors.lastname: Galli-Tsinopoulou
authors.forename: S
authors.initials: S
authors.lastname: Nousia-Arvanitakis
authors.forename: G
authors.initials: G
authors.lastname: Mitsiakos
authors.forename: M
authors.initials: M
authors.lastname: Karamouzis
authors.forename: A
authors.initials: A
authors.lastname: Dimitriadis
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000209:etiology* / Q000628:therapy; D000077465:Cabergoline; D002648:Child; D004652:Empty Sella Syndrome / Q000150:complications; D004873:Ergolines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications*; D008297:Male; D010911:Pituitary Neoplasms / Q000150:complications* / Q000175:diagnosis; D015175:Prolactinoma / Q000150:complications* / Q000175:diagnosis; D011628:Puberty, Delayed / Q000209:etiology / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D004873:Ergolines; D000077465:Cabergoline